vs

Side-by-side financial comparison of Community West Bancshares (CWBC) and Cryoport, Inc. (CYRX). Click either name above to swap in a different company.

Cryoport, Inc. is the larger business by last-quarter revenue ($45.5M vs $38.3M, roughly 1.2× Community West Bancshares). On growth, Community West Bancshares posted the faster year-over-year revenue change (11.6% vs 9.6%). Community West Bancshares produced more free cash flow last quarter ($43.6M vs $-4.5M). Over the past eight quarters, Community West Bancshares's revenue compounded faster (36.0% CAGR vs 10.4%).

Community West Bancshares is a registered bank holding company headquartered in California. It wholly owns Community West Bank under the Bank Holding Company Act.

Cryoport, Inc. is a global provider of specialized temperature-controlled logistics and supply chain solutions focused on the life sciences, biopharmaceutical, and cell and gene therapy sectors. It partners with research institutions, biotech firms, and pharmaceutical manufacturers globally to support the safe transport of sensitive biological materials including clinical trial samples and advanced therapy products.

CWBC vs CYRX — Head-to-Head

Bigger by revenue
CYRX
CYRX
1.2× larger
CYRX
$45.5M
$38.3M
CWBC
Growing faster (revenue YoY)
CWBC
CWBC
+1.9% gap
CWBC
11.6%
9.6%
CYRX
More free cash flow
CWBC
CWBC
$48.2M more FCF
CWBC
$43.6M
$-4.5M
CYRX
Faster 2-yr revenue CAGR
CWBC
CWBC
Annualised
CWBC
36.0%
10.4%
CYRX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CWBC
CWBC
CYRX
CYRX
Revenue
$38.3M
$45.5M
Net Profit
$-8.0M
Gross Margin
47.8%
Operating Margin
40.0%
-17.0%
Net Margin
-17.5%
Revenue YoY
11.6%
9.6%
Net Profit YoY
57.4%
EPS (diluted)
$0.58
$-0.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CWBC
CWBC
CYRX
CYRX
Q4 25
$38.3M
$45.5M
Q3 25
$37.9M
$44.2M
Q2 25
$35.7M
$45.5M
Q1 25
$34.8M
$41.0M
Q4 24
$34.3M
$41.5M
Q3 24
$31.3M
$38.3M
Q2 24
$30.5M
$39.7M
Q1 24
$20.7M
$37.3M
Net Profit
CWBC
CWBC
CYRX
CYRX
Q4 25
$-8.0M
Q3 25
$10.9M
$-6.9M
Q2 25
$7.8M
$105.2M
Q1 25
$8.3M
$-12.0M
Q4 24
$-18.7M
Q3 24
$3.4M
$805.0K
Q2 24
$-6.3M
$-78.0M
Q1 24
$3.7M
$-18.9M
Gross Margin
CWBC
CWBC
CYRX
CYRX
Q4 25
47.8%
Q3 25
48.2%
Q2 25
47.0%
Q1 25
45.4%
Q4 24
47.0%
Q3 24
45.5%
Q2 24
44.5%
Q1 24
40.4%
Operating Margin
CWBC
CWBC
CYRX
CYRX
Q4 25
40.0%
-17.0%
Q3 25
39.8%
-22.5%
Q2 25
30.2%
-21.2%
Q1 25
32.7%
-23.1%
Q4 24
31.0%
-30.7%
Q3 24
13.3%
-34.9%
Q2 24
-25.9%
-196.5%
Q1 24
23.2%
-46.9%
Net Margin
CWBC
CWBC
CYRX
CYRX
Q4 25
-17.5%
Q3 25
28.7%
-15.7%
Q2 25
22.0%
231.4%
Q1 25
23.8%
-29.2%
Q4 24
-45.1%
Q3 24
10.8%
2.1%
Q2 24
-20.7%
-196.4%
Q1 24
17.8%
-50.7%
EPS (diluted)
CWBC
CWBC
CYRX
CYRX
Q4 25
$0.58
$-0.19
Q3 25
$0.57
$-0.18
Q2 25
$0.41
$2.05
Q1 25
$0.44
$-0.28
Q4 24
$0.29
$-0.42
Q3 24
$0.18
$-0.02
Q2 24
$-0.33
$-1.62
Q1 24
$0.31
$-0.43

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CWBC
CWBC
CYRX
CYRX
Cash + ST InvestmentsLiquidity on hand
$119.0M
$411.2M
Total DebtLower is stronger
$69.5M
Stockholders' EquityBook value
$409.6M
$502.6M
Total Assets
$3.7B
$765.0M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CWBC
CWBC
CYRX
CYRX
Q4 25
$119.0M
$411.2M
Q3 25
$121.6M
$421.3M
Q2 25
$134.4M
$426.0M
Q1 25
$148.4M
$244.0M
Q4 24
$120.4M
$250.6M
Q3 24
$149.0M
$259.4M
Q2 24
$109.7M
$414.9M
Q1 24
$61.0M
$438.2M
Total Debt
CWBC
CWBC
CYRX
CYRX
Q4 25
$69.5M
Q3 25
Q2 25
Q1 25
Q4 24
$69.9M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CWBC
CWBC
CYRX
CYRX
Q4 25
$409.6M
$502.6M
Q3 25
$397.6M
$513.3M
Q2 25
$380.0M
$519.1M
Q1 25
$372.2M
$398.8M
Q4 24
$362.7M
$401.9M
Q3 24
$363.5M
$418.6M
Q2 24
$350.2M
$400.1M
Q1 24
$211.7M
$472.2M
Total Assets
CWBC
CWBC
CYRX
CYRX
Q4 25
$3.7B
$765.0M
Q3 25
$3.6B
$774.3M
Q2 25
$3.6B
$773.9M
Q1 25
$3.6B
$699.8M
Q4 24
$3.5B
$703.5M
Q3 24
$3.5B
$701.8M
Q2 24
$3.5B
$852.3M
Q1 24
$2.4B
$942.8M
Debt / Equity
CWBC
CWBC
CYRX
CYRX
Q4 25
0.17×
Q3 25
Q2 25
Q1 25
Q4 24
0.19×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CWBC
CWBC
CYRX
CYRX
Operating Cash FlowLast quarter
$46.1M
$919.0K
Free Cash FlowOCF − Capex
$43.6M
$-4.5M
FCF MarginFCF / Revenue
113.9%
-10.0%
Capex IntensityCapex / Revenue
6.6%
12.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$77.7M
$-25.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CWBC
CWBC
CYRX
CYRX
Q4 25
$46.1M
$919.0K
Q3 25
$13.2M
$2.2M
Q2 25
$11.5M
$-7.3M
Q1 25
$11.1M
$-4.3M
Q4 24
$22.2M
$-5.5M
Q3 24
$7.8M
$447.0K
Q2 24
$5.2M
$-8.0M
Q1 24
$4.0M
$-3.3M
Free Cash Flow
CWBC
CWBC
CYRX
CYRX
Q4 25
$43.6M
$-4.5M
Q3 25
$12.8M
$-1.3M
Q2 25
$10.6M
$-11.7M
Q1 25
$10.8M
$-7.5M
Q4 24
$17.2M
$-10.7M
Q3 24
$5.2M
$-3.8M
Q2 24
$4.8M
$-11.8M
Q1 24
$3.6M
$-7.3M
FCF Margin
CWBC
CWBC
CYRX
CYRX
Q4 25
113.9%
-10.0%
Q3 25
33.7%
-2.9%
Q2 25
29.6%
-25.7%
Q1 25
30.9%
-18.3%
Q4 24
50.0%
-25.8%
Q3 24
16.7%
-9.9%
Q2 24
15.7%
-29.8%
Q1 24
17.3%
-19.5%
Capex Intensity
CWBC
CWBC
CYRX
CYRX
Q4 25
6.6%
12.0%
Q3 25
1.1%
7.8%
Q2 25
2.7%
9.6%
Q1 25
0.9%
7.7%
Q4 24
14.7%
12.6%
Q3 24
8.1%
11.1%
Q2 24
1.4%
9.5%
Q1 24
2.1%
10.7%
Cash Conversion
CWBC
CWBC
CYRX
CYRX
Q4 25
Q3 25
1.21×
Q2 25
1.47×
-0.07×
Q1 25
1.33×
Q4 24
Q3 24
2.29×
0.56×
Q2 24
Q1 24
1.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons